Medicamen Biotech Ltd disclosed annual information about substantial share acquisitions by promoters for the financial year ending March 31, 2025, in compliance with SEBI regulations.
AI Assistant
Medicamen Biotech Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.